AG

Adam Gazzaley

Executive Director, Neuroscape at UCSF Medical Center

San Francisco, California

Overview 

Adam Gazzaley is the Founder and Executive Director of Neuroscape at UCSF, where he leads groundbreaking research in neuroscience and cognition. He is also the Co-Founder, Board Member, and Chief Science Advisor at Akili, showcasing his expertise in the development of innovative technologies for healthcare. Gazzaley's career highlights include leading research in neurology, psychiatry, and physiology at UCSF, as well as co-founding and serving as Chief Science Advisor at Akili Interactive Labs, demonstrating his commitment to advancing the field of cognitive neuroscience through cutting-edge technology.

Work Experience 

U

UCSF

  • Professor of Neurology, Psychiatry and Physiology

    2005 - Current

UM

UCSF Medical Center

  • Executive Director, Neuroscape

    2017

    Neuroscape is a translational neuroscience center at UCSF engaged in technology creation and scientific research to better assess and optimize brain function of both healthy and impaired individuals.

AI

Akili Interactive Labs

  • Co-Founder and Chief Science Advisor

    2011

    At Akili, we're in the process of building clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like high-quality video games. Our aim is to develop a new type of Electronic Medicine™ that can be deployed remotely directly to any patient anywhere, prescribed and tracked by physicians, with the potential to be developed at a fraction of the cost of traditional medical approaches

Akili is a digital therapeutics company that offers Innovative video game-based therapies for neurological and psychiatric conditions.

Raised $270,590,000.00 from Fearless Ventures, Omidyar Technology Ventures, Shionogi, QUAD Investment Management, Jazz Venture Partners, M Ventures, Neuberger Berman, David Baszucki, Mirae Asset and Evidity Health Capital.

akiliinteractive.com
JV

JAZZ Venture Partners

  • Co Founder and Chief Scientist

    2015

    JAZZ Venture Partners invests in experiential technologies (XTech) that improve human performance -- emerging companies leveraging the convergence of new digital technology platforms (e.g. virtual and augmented reality, immersive videogaming, artificial intelligence, deep learning, brain-computer interfaces, robotics) with recent advances in neuroscience that are creating entirely new ways to improve the human experience. These companies are impacting multiple $100+ billion industries including health, mind-body wellness, peak mental and physical acuity, accelerated learning and training, sports, and entertainment.

JAZZ Venture Partners is a venture capital firm focused on technologies that extend the boundaries of human performance.

jazzvp.com
S

Sensync

  • Co-Founder and Chief Science Advisor

    2018 - 2021

Education 

Articles About Adam

Relevant Websites